FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

3601611000001101: Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
227271000001116 Rhinolast 140micrograms/dose nasal spray (Mylan) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
227281000001119 Rhinolast 140micrograms/dose nasal spray (Mylan) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2126141000001119 Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2126151000001116 Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
17391101000001113 Rhinolast 140micrograms/actuation nasal spray (Viatris Pharmaceuticals Ltd) (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17391201000001118 Rhinolast 140micrograms/actuation nasal spray (Viatris Pharmaceuticals Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38246701000001112 Rhinolast 140micrograms/actuation nasal spray (Meda Pharmaceuticals Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
58718401000001111 Rhinolast 140micrograms/dose nasal spray (Meda Pharmaceuticals Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Is a Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has excipient Edetate disodium false Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has active ingredient Azelastine hydrochloride false Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has manufactured dose form Spray dose form false Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Is a Rhinolast true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has specific active ingredient Azelastine hydrochloride true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has manufactured dose form Nasal dose form true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 20 ml Is pack of False Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 22 ml Is pack of False Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 22 ml Has AMP True Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 20 ml Has AMP True Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start